Warrant
Issued 2019
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 53 of Atara Biotherapeutics, Inc.'s SEC filings and found 7 warrant series, 2 ATM programs, 2 shelf registrations and 3 completed offerings on file for ATRA. The latest dilution event on file is an offering on Sep 4, 2026. Analysis updated Nov 2, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 60 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Sep 4, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2019
Shares Underlying
Exercise Price
Issued 2020
Shares Underlying
Exercise Price
Issued 2020
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2023
Total capacity
Sold to date
Issued 2021
Total capacity
Sold to date
Issued 2023
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z